Decoding resistance in Diutina catenulata by validating clinically relevant Erg11/Fks1 mutations
Frontiers in Cellular and Infection Microbiology · 17.02.2026 · 16
DOI: 10.3389/fcimb.2026.1776442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 17.02.2026. Verfasst von Wei Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Key Laboratory of Pathogenic Mechanisms and Diagnosis & Treatment Technologies for Lung Microbiome, The First Affiliated Hospital of Hebei Nort…. Hauptthemen laut MEDLINE: Drug Resistance, Fungal, Antifungal Agents, Mutation, Fungal Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To verify the causal relationship between specific mutations in the ERG11 and FKS1 genes and antifungal drug resistance in clinical isolates of Diutina catenulata .
Methods
Recombinant plasmids expressing mutant alleles of ERG11 (F126L, K143R) or FKS1 (F621I, S1123G, I1348S, and the triple mutant S625L/S1123G/F1354L) were constructed and functionally validated in a Saccharomyces cerevisiae W303-1a model. Susceptibility testing was performed under different nutrient conditions (SD-Ura and YPD). Molecular docking analysis was conducted to elucidate the structural mechanisms of resistance.
Results
Functional validation in S. cerevisiae confirmed that both ERG11 and FKS1 mutations conferred resistance in a nutrient-dependent manner. The ERG11 -F126L mutation increased the fluconazole MIC by 21-fold in SD-Ura compared to YPD. FKS1 mutations led to 1.4 to 2-fold increases in echinocandin MICs. Molecular docking revealed the mechanistic bases: ERG11 -F126L expanded the ligand-binding cavity (ΔΔG +1.2 kcal/mol), FKS1 -F621I disrupted hydrophobic interactions, and compound mutations synergistically perturbed ATP-binding domains.
Conclusion
Specific mutations in ERG11 (F126L, K143R) and FKS1 (F621I and hotspot variants) are the primary drivers of the pronounced antifungal resistance observed in Chinese D. catenulata strains, with resistance phenotypes being modulated by nutrient availability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hebei Key Laboratory of Pathogenic Mechanisms and Diagnosis & Treatment Technologies for Lung Microbiome, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei, China.
- Hebei Key Laboratory of Pathogens and Epidemiology of Infectious Diseases, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
- Department of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Zitieren
APA
Zhang, W., Wang, N., Chen, X. F., He, B. H., Xiao, M., Xu, Y. C., & Li, Q. (2026). Decoding resistance in Diutina catenulata by validating clinically relevant Erg11/Fks1 mutations. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1776442
Vancouver
Zhang W, Wang N, Chen XF, He BH, Xiao M, Xu YC, et al. Decoding resistance in Diutina catenulata by validating clinically relevant Erg11/Fks1 mutations. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1776442
BibTeX
@article{Zhang2026,
author = {Zhang, Wei and Wang, Na and Chen, Xin-Fei and He, Bao-Hua and Xiao, Meng and Xu, Ying-Chun and Li, Qi},
title = {Decoding resistance in Diutina catenulata by validating clinically relevant Erg11/Fks1 mutations},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1776442}
}
EUVIMED